We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.65 | 2.30 | 3.00 | - | 0.00 | 13:55:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 5.03M | -2.44M | -0.0083 | -3.19 | 7.82M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/4/2024 14:50 | 2M @ 2.6p wouldn't help much with my tax | mashman | |
06/4/2024 00:06 | Tuco, tax. | chutes01 | |
05/4/2024 22:46 | 2000000 at 2.6, late reporting, that's what has done the damage. Desperate seller or someone in the know? | goggin | |
05/4/2024 06:25 | I am waiting on the NDA excuse by the way. | peverill | |
05/4/2024 06:25 | Are pools and wasjobber one and the same.They have a knack of both putting 2+2 together to make 5.Where anywhere does it say the NHS are using PRM markers in these trials,Given PRM's precarious position you would think they would be shouting from the rooftops if true. | peverill | |
04/4/2024 18:49 | New NHS Alzheimer's disease trials: - "Teams from the University of Oxford and University College London will lead the trials to research the use of tests to detect proteins for people with early stages of dementia." University College London - Proteome Sciences has long term collaboration in AD Simon Lovestone - Proteome Sciences has long term collaboration in AD Dementias Platform UK based at the Department of Psychiatry, University of Oxford - Proteome Sciences has long term collaboration in AD “It’s fantastic that through collaborating with the leading experts in the dementia community, we can look to bring cutting-edge blood tests for diagnosing dementia within the NHS." -------------------- These news NHS trials are using Proteome Sciences patented AD biomarkers. | pools2 | |
04/4/2024 16:58 | to be fair, prm always rns a 'notice of results' first to allow holders a window to sell before the sh*t hits the fan agsin | elpirata | |
04/4/2024 14:35 | Finals due tomorrow -they are usually this week- noy that I am expecting anything exciting as we have heard zero since the profits warning 6 months ago ! | base7 | |
04/4/2024 11:17 | Wait till results,Mrs S has done us the world of good and well paid too,fair play to her. | peverill | |
04/4/2024 11:02 | It'll pass prm by like covid, stroke, bse etc 2.5p on the bid the BoD should be ashamed | elpirata | |
03/4/2024 20:01 | ...rather longer than expected...... | dominiccummings | |
03/4/2024 17:59 | No, it is certainly not a scam. Things have taken rather longer than expected, and some (one?) of the directors was very overoptimistic. | goatherd | |
03/4/2024 16:43 | Why is this company even listed,they should be struck off for wasting peoples time and money,is it a scam??? | peverill | |
02/4/2024 17:02 | :-) He must have been very perceptive to have had experience as a shareholder in a company founded 7 years after his death, | goatherd | |
02/4/2024 16:05 | Beckett was famed for his ability to see into the future as it happens goatherd. | dominiccummings | |
02/4/2024 16:02 | Nice one, Pram. Even if a little doubtful historically. Waiting for Godot had its premiere in 1953, some 41 years before Proteome was founded. | goatherd | |
02/4/2024 15:45 | I understand that Sam Beckett based his play "Waiting for Godot" on his experience as a small PRM shareholder. | dominiccummings | |
02/4/2024 13:47 | Is it like the news from the early years.still waiting for that news nearly 30 years on. | peverill | |
02/4/2024 09:33 | incoming new kitchen STRONG DONT BUY | elpirata | |
02/4/2024 08:48 | We've been 'due news' for decades. News came there none.... at least none good. | dominiccummings | |
02/4/2024 06:42 | Are we due news??. | peverill | |
28/3/2024 21:24 | I'll email you | dominiccummings |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions